newsfilter
← Latest News
Business Wire·

CEL-SCI Reports Fiscal Third Quarter 2026 Results

Peer-reviewed study in Oral Oncology identified prognostic biomarkers for selecting patients most likely to achieve substantial survival benefit from Multikine in upcoming Confirmatory Head & Neck Cancer